Dr. Bert H O'Neil, MD
Claim this profileCommunity Health Network
Studies Lung Cancer
Studies Colorectal Cancer
8 reported clinical trials
19 drugs studied
Area of expertise
1Lung Cancer
Stage IV
PD-L1 positive
Stage III
2Colorectal Cancer
Stage IV
PD-L1 positive
PD-L1 negative
Affiliated Hospitals
Clinical Trials Bert H O'Neil, MD is currently running
Ivaltinostat + Capecitabine
for Pancreatic Cancer
This trial tests ivaltinostat with capecitabine in patients with advanced pancreatic cancer who have not worsened after initial treatment. The goal is to find a safe and effective dose and to see if this combination can better control the cancer. Capecitabine is a medication that is converted into another drug in the body, showing better selectivity and tolerability in tumor tissues.
Recruiting3 awards Phase 1 & 211 criteria
ART0380
for Advanced Cancer
This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to: * Find the recommended dose of ART0380 that can be given safely to participants alone and in combination with gemcitabine or irinotecan * Learn more about the side effects of ART0380 alone and in combination with gemcitabine or irinotecan * Learn more about the effectiveness of ART0380 alone and in combination with gemcitabine or irinotecan
Recruiting1 award Phase 1 & 214 criteria
More about Bert H O'Neil, MD
Clinical Trial Related7 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Bert H O'Neil, MD has experience with
- KBP-5209
- ZL-1211
- Trastuzumab
- Aromatase Inhibitor (AI)
- Pertuzumab
- Abemaciclib
Breakdown of trials Bert H O'Neil, MD has run
Lung Cancer
Colorectal Cancer
Solid Tumors
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bert H O'Neil, MD specialize in?
Bert H O'Neil, MD focuses on Lung Cancer and Colorectal Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is Bert H O'Neil, MD currently recruiting for clinical trials?
Yes, Bert H O'Neil, MD is currently recruiting for 2 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Bert H O'Neil, MD has studied deeply?
Yes, Bert H O'Neil, MD has studied treatments such as KBP-5209, ZL-1211, Trastuzumab.
What is the best way to schedule an appointment with Bert H O'Neil, MD?
Apply for one of the trials that Bert H O'Neil, MD is conducting.
What is the office address of Bert H O'Neil, MD?
The office of Bert H O'Neil, MD is located at: Community Health Network, Indianapolis, Indiana 46250 United States. This is the address for their practice at the Community Health Network.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.